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Editorial
Dear Readers,
Cachexia is one of the most disturbing symptom in advanced malignant neoplasms, however the classifi-
cation of cachexia is currently being revised to improve design of clinical trials and patient care [1]. Assess-
ment of cachexia requires multimodal subjective instruments, and outcome monitoring necessitate varies
cofactors to be considered. Baczyk et al. performed a broad analysis of factors potentially contributing to
cachexia. Authors found a correlation between weight loss and worse pain control, higher grade of depre-
ssion and higher serum level of cortisol. There was also a tendency to higher TNF-alpha and IL-6 serum levels
in cachectic patients, markers that are commonly increased in advanced muscle loss [2]. Some authors
suggest that pro-inflammatory cytokines may serve as a marker of early detection of cachexia [3].
Chronic pain remains a paramount problem in advanced cancer patients. Unfortunately, not all patients
respond adequately to pharmacological treatment, and this may lead to a deterioration of the quality of life,
a limitation of function and unacceptable side effects related to increasing doses of analgetics. Boroń and
Woźniewski showed that one month of exercise training allowed for limiting of pain intensity, decreasing
doses of analgetics and increasing physical activity of patients with chronic cancer-related pain.
Two case reports complete the part of issue dedicated to symptom control — the report on chronic
pleural effusion accompanying chronic liver failure (Damps-Konstańska et al.), and chronic pain diagnosed as
myofascial and nerve compression pain (Wolfs and Zylicz). In both cases no standard treatment is recommen-
ded and final outcomes depend on several additional factors.
Finally, I would like to pay your attention also to two other papers dealing. The first one indicates an
important problem of nutrition. Sopata and co-authors discussed about the methods of oral, enteral and
parenteral nutrition in palliative medicine.
Recently American College of Chest Physician (ACCP) recommended the use of computed cough analyzers
in monitoring of cough and effectiveness of anti-tussive treatment [4]. Unfortunately, reliable device diffe-
rentiating between cough and other sounds, use to use in the ambulatory setting is still lacking. Krajnik et al.
challenged the idea of constructing the cough monitor based on recording of vibro-acoustic signals.
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